Huber Engineered Woods LLC v. Georgia-Pacific Wood Products LLC (Western District of North Carolina) - Represented manufacturer of engineered wood products in patent and unfair competition litigation relating to innovating structural roof and wall sheathing systems.
Crown Labs, Inc. v. PureTek Corp. et al. (Eastern District of Tennessee) - Representing producer of pharmaceutical and personal care products in Lanham Act and unfair competition litigation relating to sale of packaged medical products.
Chiesi USA, Inc., et al. v. Exela Pharma Sciences, LLC, et al. (District of Delaware) – Represented major pharmaceutical company in a Hatch-Waxman case relating to the drug nicardipine.
Antennatech LLC v. The Coca-Cola Company (District of Delaware) – Represented world’s largest drink manufacturer in patent litigation relating to near-field communication electronics technology.
MPHJ Tech. Investments, LLC v. The Coca-Cola Company (District of Delaware) – Represented world’s largest drink manufacturer in patent litigation relating to copy machine technology.
Grayhawk Homes, Inc. v. Woodruff Contracting Co., LLC (Middle District of Georgia) – Represented one of the nation’s largest home builders in copyright litigation enforcing copyrights of unique architectural home designs.
Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS and Xellia Pharmaceuticals, Inc. (District of Delaware) – Represented major pharmaceutical company in the trial of a Hatch-Waxman case relating to the drug caspofungin acetate.
Takeda Pharmaceuticals, et al. v. Teva Pharmaceuticals, et al. (District of Delaware) – Represented one of the world’s largest pharmaceutical companies in the trial of a Hatch-Waxman case relating to the drug lansoprazole, which has an annual market of more than $3 billion.
Brigham & Women’s Hospital, et al. v. Teva Pharmaceuticals, et al. (District of Delaware) – Represented one of the world’s largest pharmaceutical companies in the trial of a Hatch-Waxman case relating to the drug cinacalcet, which has an annual market of more than $400 million.
Takeda Pharmaceuticals, et al. v. Teva Pharmaceuticals, et al. (Southern District of New York) – Represented one of the world’s largest pharmaceutical companies in a Hatch-Waxman case relating to the drug pioglitazone, which has an annual market of more than $2.5 billion.
Teva Pharmaceuticals v. AstraZeneca L.P., et al. (Eastern District of Pennsylvania) – Represented one of the world’s largest pharmaceutical companies in enforcement of patent relating to the drug rosuvastatin. Representation included oral argument on behalf of client at the U.S. Court of Appeals for the Federal Circuit.
In the Matter of Certain Alendronate Salts and Products Containing Same (U.S.I.T.C.) – Represented the defendant manufacturer of an active pharmaceutical ingredient in drugs used to treat osteoporosis in a Section 337 action before the U.S. International Trade Commission.
Texas Instruments v. Linear Technology Corp. (Eastern District of Texas) – Represented semiconductor manufacturer in patent infringement litigation relating to manufacture of semiconductor circuitry.
Premier Networks v. Lucent Technologies and AT&T (Northern District of Illinois) – Represented leading telephone companies in patent infringement litigation relating to telephone circuitry.
Via Technologies, et al. v. Intel (Western District of Texas) – Represented microprocessor manufacturer in patent infringement action relating to microprocessor hardware and software.